Expiring federal contract · order under a contract vehicle
75A50126F61013 — Seqirus INC
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Contract / PIID
- 75A50126F61013
- Incumbent
- Seqirus INC
- Incumbent UEI
- Z6N1LJ2RD6E3
- Current end date
- May 8, 2027
- Potential total value
- $450,052
- Obligated
- $450,052
- NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- April 2, 2026
- Place of performance
- NC
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.
What the contract covers
TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO CONFIRM IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PROTOTYPE STRAIN
Likely rebid window (estimate)
- Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
- RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)
Between the estimated Sources Sought and RFP windows.
This is an order under contract vehicle 75A50122D00004. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 1 recorded change to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325414)
- 75A50125C00002 — Sanofi Vaccines US INC. · ends January 31, 2027 · $53M
- 75A50124F61004 — Advanced Technology International · ends April 11, 2027 · $51M
- 75N93023P00594 — Dna Twopointo INC. · ends May 13, 2027 · $300K
- 75N98026P00545 — Somalogic Operating CO., INC · ends May 14, 2027 · $522K
- 75A50124F61008 — Seqirus INC · ends May 21, 2027 · $23M
- 75A50124F61009 — Seqirus INC · ends May 21, 2027 · $396K
- 75N98026P00626 — Olink Proteomics INC · ends May 28, 2027 · $207K
- 75N98026P00928 — Pacific Biosciences Of California, INC · ends July 7, 2027 · $347K
- 75N98026P01001 — Life Technologies Corporation · ends August 6, 2027 · $110K
- 75N98026F00001 — Roche Diagnostics Corporation · ends August 31, 2027 · $127K